Reporting owner

Clase Neera

Reporting owner CIK 0002162845 · Chief Commercial Officer

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page0

Other acquisitions2

Reporting owners1

SalesNot providedCheck original SEC filings

Nov 3, 2026 – Nov 3, 2026 · Transaction dates · Current page sample

Reported quantity · derivative units

Tarsus Pharmaceuticals, Inc. · Restricted Stock Units · Stock award (code A) · Derivative · Currency not specified

Swipe the chart to see the full date range. Exact records are available in the table below.

1 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions in this page sample · 1 reporting owners.

View timeline as a table

Transaction date	Company / security	Reporting owners	Acquisition type	Quantity	Price	Reference value	Currency
Nov 3, 2026	Tarsus Pharmaceuticals, Inc.Restricted Stock Units	Clase Neera (Chief Commercial Officer)	Stock award	6,678	0	0	Currency not specified
Nov 3, 2026	Tarsus Pharmaceuticals, Inc.Stock Option (right to buy)	Clase Neera (Chief Commercial Officer)	Stock award	10,587	0	0	Currency not specified

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transacted	Company	Reporting owners	Type / security	Quantity	Price / reference value	Details
Nov 5, 2026Trade: Nov 3, 2026	Tarsus Pharmaceuticals, Inc.TARS · company listings	Clase NeeraChief Commercial Officer	Stock awardRestricted Stock UnitsDerivative security · Code A	6,678	0Value: 0Currency not specified	View ↗
Nov 5, 2026Trade: Nov 3, 2026	Tarsus Pharmaceuticals, Inc.TARS · company listings	Clase NeeraChief Commercial Officer	Stock awardStock Option (right to buy)Derivative security · Code A	10,587	0Value: 0Currency not specified	View ↗

2 transactions on this page. Filing date, newest first.